CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, ...

On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical ...

The primary contractor for the project will be appointed next week. Keturah completes infrastructure work on Dubai’s first ...

Ariel Investments, an investment management company, released its “Ariel Focus Fund” third-quarter 2024 investor letter. A ...

PK Study Successfully Demonstrates that Fingerprint Sweat Provides Reliable Sample for Drug Detection. FDA 510(k) Clearance ...

Shares of Avidity Biosciences surged to a record high Wednesday after the company showed its hand in the cardiovascular space ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of ...

PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) this week reported its third quarter financial results for 2024, ...

Vivek Ramaswamy has withdrawn from the Ohio Senate race to support Trump's initiative with Elon Musk on government efficiency ...

"We are excited to have completed administering first doses to all patients enrolled in our phase 2 Alzheimer's trial,” ...

Analysts estimate that bluebird bio will report an earnings per share (EPS) of $-0.37. Anticipation surrounds bluebird bio's announcement, with investors hoping to hear about both surpassing estimates ...

Professional MAGA content creators somehow think that they have a realistic chance of landing a senior role in ...